Results 181 to 190 of about 31,441 (254)

Direct Comparative Safety and Anatomical Performance of Amulet Versus Watchman Devices for Left Atrial Appendage Occlusion. [PDF]

Cureus
Silva Rojas G, Silva-Rojas KJ, Zea Olvera AN, Farfan Cano GG.   +3 more
europepmc   +1 more source

Risk Factors for Bleeding Following Combined Catheter Ablation and Left Atrial Appendage Occlusion in Patients With Nonvalvular Atrial Fibrillation and Low Baseline Bleeding Risk: An Exploratory Analysis. [PDF]

Cureus
Ren H, Lai H, Chen Z.
europepmc   +1 more source

Combined Single-Access Left Atrial Appendage Occlusion and Transcatheter Edge-to-Edge Repair for Mitral and Tricuspid Regurgitation. [PDF]

JACC Case Rep
Florescu AG, Neylon A, Duhamel S, Djebbar M, Akodad M, Garot P.   +5 more
europepmc   +1 more source

Left atrial appendage occlusion device

, 2015
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Percutaneous left atrial appendage occlusion

Current Opinion in Cardiology, 2021
Purpose of review To review recent evidence evaluating the long-term safety and efficacy outcomes of left atrial appendage occlusion (LAAO), current guideline recommendations for LAAO use, performance of LAAO in comparison with direct oral anticoagulants (DOAC) and recently approved LAAO device.
Moghniuddin, Mohammed, Sagar, Ranka, Madhu, Reddy   +2 more
openaire   +2 more sources

Left atrial appendage occlusion

Interventional Cardiology Clinics, 2018
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, affecting 1.5–2% of the general population and more than 8% of those older than 80 years. Because of the progressive ageing of our population, an exponential increase in incidence is expected over the next few decades.
Sandeep Panikker, Tim Betts, Milena Leo
  +4 more sources